Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Reports Rise in Sales, Decreased Income

SAN FRANCISCO, Aug. 5 - Qiagen today reported a 10 percent increase in sales.


Net sales for the second quarter ended June 30 were $72.7 million compared with $66 million one year ago.


Net income for the quarter, excluding the one-time charges from the acquisition of GenoVision in the second quarter 2002, decreased to $4.6 million, or $ .05 per diluted earnings per share, from $11.3 million, or $.08 per diluted earnings per share, for the year-ago period.


R&D spending dropped to approximately $6.7 million compared to $7 million for the second quarter in 2001.


Qiagen said it had roughly $39.5 million in cash and cash equivalents as of June 30.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.